If healthcare AI is to improve care and efficiency in clinical practice across medicine, its proponents in radiology must implement it in a structured manner.
Cigna, one of the nation’s largest health insurance companies, has expanded its virtual support services for mental and emotional health by adding Talkspace to its behavioral provider network.
It was late April when the CDC added impaired taste and/or smell to its list of COVID-19 symptoms. Thanks to AI and natural language processing (NLP), researchers at the Medical University of South Carolina had beaten the federal agency to the punch.
AI enthusiasts have varying aims and incentives for pushing the technology into healthcare, but many parrot a common set of justifications. Do any of these sound familiar?
More than 1,750 standalone Medicare Part D prescription drug plans and MA plans have applied to offer insulin at a maximum $35 copay for a month’s supply of the drug for the 2021 plan year, CMS announced.
Researchers have demonstrated a way to visually explore small-molecule inhibitors that, according to algorithmic suggestions, show potential for targeting COVID-19’s main proteins.
While employment levels of most healthcare sectors rebounded to pre-COVID levels in 2021, the researchers found there was a 13.6% decline in employment at skilled nursing facilities compared to 2019.
Healthcare AI startups are asserting AI’s fitness for the fight against COVID-19. How’s that working from the perspective of healthcare providers?
The healthcare sector has seen an influx of funding from private equity groups over the last several years, aiding in the contraction of the industry. But has the influence of cash been beneficial for healthcare?
